Page last updated: 2024-08-24

repaglinide and Idiopathic Parkinson Disease

repaglinide has been researched along with Idiopathic Parkinson Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Abdelraouf, SM; Al-Kady, RH; Motawi, TK; Senousy, MA	1

Other Studies

1 other study(ies) available for repaglinide and Idiopathic Parkinson Disease

Article	Year
Repaglinide Elicits a Neuroprotective Effect in Rotenone-Induced Parkinson's Disease in Rats: Emphasis on Targeting the DREAM-ER Stress BiP/ATF6/CHOP Trajectory and Activation of Mitophagy. ACS chemical neuroscience, 2023, 01-04, Volume: 14, Issue:1 Topics: Activating Transcription Factor 6; Animals; Apoptosis; Calcium; Endoplasmic Reticulum Stress; Kv Channel-Interacting Proteins; Male; Mitophagy; Neuroinflammatory Diseases; Neuroprotective Agents; Parkinson Disease; Rats; Rats, Wistar; Rotenone; Transcription Factor CHOP	2023

Article

Year

Repaglinide Elicits a Neuroprotective Effect in Rotenone-Induced Parkinson's Disease in Rats: Emphasis on Targeting the DREAM-ER Stress BiP/ATF6/CHOP Trajectory and Activation of Mitophagy.

ACS chemical neuroscience, 2023, 01-04, Volume: 14, Issue:1

Topics: Activating Transcription Factor 6; Animals; Apoptosis; Calcium; Endoplasmic Reticulum Stress; Kv Channel-Interacting Proteins; Male; Mitophagy; Neuroinflammatory Diseases; Neuroprotective Agents; Parkinson Disease; Rats; Rats, Wistar; Rotenone; Transcription Factor CHOP

2023